Development and Validation of a Novel Tool to Predict Model for End-Stage Liver Disease (MELD) Scores in Cirrhosis, Using Administrative Datasets

References

• Beste LA, Leipertz SL, Green PK, et al. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001–2013. Gastroenterology. 2015;149(6):1471–82e5; quiz e17–8. doi:10.1053/j.gastro.2015.07.056
   PubMed Web of Science ®Google Scholar
• Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999–2016: observational study. BMJ. 2018;362:k2817. doi:10.1136/bmj.k2817
   PubMed Web of Science ®Google Scholar
• Estes C, Razavi H, Loomba R, et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67(1):123–133. doi:10.1002/hep.29466
   PubMed Web of Science ®Google Scholar
• Rodrigues SG, Mendoza YP, Bosch J. Beta-blockers in cirrhosis: evidence-based indications and limitations. JHEP Rep. 2020;2(1):100063. doi:10.1016/j.jhepr.2019.12.001
   PubMedGoogle Scholar
• Elkrief L, Rautou PE, Sarin S, et al. Diabetes mellitus in patients with cirrhosis: clinical implications and management. Liver Int. 2016;36(7):936–948. doi:10.1111/liv.13115
   PubMed Web of Science ®Google Scholar
• Qamar A, Vaduganathan M, Greenberger NJ, et al. Oral anticoagulation in patients with liver disease. J Am Coll Cardiol. 2018;71(19):2162–2175. doi:10.1016/j.jacc.2018.03.023
   PubMed Web of Science ®Google Scholar
• Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–470. doi:10.1053/jhep.2001.22172
   PubMed Web of Science ®Google Scholar
• Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124(1):91–96. doi:10.1053/gast.2003.50016
   PubMed Web of Science ®Google Scholar
• Hagstrom H, Adams LA, Allen AM, et al. Administrative coding in electronic health care record-based research of NAFLD: an expert panel consensus statement. Hepatology. 2021;74(1):474–482. doi:10.1002/hep.31726
   PubMed Web of Science ®Google Scholar
• Desai RJ, Lin KJ, Patorno E, et al. Development and preliminary validation of a medicare claims-based model to predict left ventricular ejection fraction class in patients with heart failure. Circ Cardiovasc Qual Outcomes. 2018;11(12):e004700. doi:10.1161/CIRCOUTCOMES.118.004700
   PubMed Web of Science ®Google Scholar
• Mahesri M, Chin K, Kumar A, et al. External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure. PLoS One. 2021;16(6):e0252903. doi:10.1371/journal.pone.0252903
   PubMed Web of Science ®Google Scholar
• Kim DH, Schneeweiss S, Glynn RJ, et al. Measuring frailty in medicare data: development and validation of a claims-based frailty index. J Gerontol a Biol Sci Med Sci. 2018;73(7):980–987. doi:10.1093/gerona/glx229
   PubMed Web of Science ®Google Scholar
• Bengtsson B, Askling J, Ludvigsson JF, et al. Validity of administrative codes associated with cirrhosis in Sweden. Scand J Gastroenterol. 2020:1–6. doi:10.1080/00365521.2020.1820566
   Web of Science ®Google Scholar
• Goldberg D, Lewis J, Halpern S, et al. Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database. Pharmacoepidemiol Drug Saf. 2012;21(7):765–769. doi:10.1002/pds.3290
   PubMed Web of Science ®Google Scholar
• Mapakshi S, Kramer JR, Richardson P, et al. Positive predictive value of international classification of diseases, 10th revision, codes for cirrhosis and its related complications. Clin Gastroenterol Hepatol. 2018;16(10):1677–1678. doi:10.1016/j.cgh.2018.01.042
   PubMed Web of Science ®Google Scholar
• Tapper EB, Korovaichuk S, Baki J, et al. Identifying patients with hepatic encephalopathy using administrative data in the ICD-10 era. Clin Gastroenterol Hepatol. 2019. doi:10.1016/j.cgh.2019.12.017
   Web of Science ®Google Scholar
• Merion RM. When is a patient too well and when is a patient too sick for a liver transplant? Liver Transpl. 2004;10(10Suppl 2):S69–S73. doi:10.1002/lt.20265
   PubMedGoogle Scholar
• Martin AP, Bartels M, Hauss J, et al. Overview of the MELD score and the UNOS adult liver allocation system. Transplant Proc. 2007;39(10):3169–3174. doi:10.1016/j.transproceed.2007.04.025
   PubMed Web of Science ®Google Scholar
• Lin KJ, Singer DE, Glynn RJ, et al. Prediction score for anticoagulation control quality among older adults. J Am Heart Assoc. 2017;6(10). doi:10.1161/JAHA.117.006814
   Web of Science ®Google Scholar
• Sellers CM, Uhlig J, Ludwig JM, et al. The impact of socioeconomic status on outcomes in hepatocellular carcinoma: inferences from primary insurance. Cancer Med. 2019;8(13):5948–5958. doi:10.1002/cam4.2251
   PubMed Web of Science ®Google Scholar
• Robinson A, Hirode G, Wong RJ. Ethnicity and insurance-specific disparities in the model for end-stage liver disease score at time of liver transplant waitlist registration and its impact on mortality. J Clin Exp Hepatol. 2021;11(2):188–194. doi:10.1016/j.jceh.2020.07.011
   PubMedGoogle Scholar
• Asrani SK, Kouznetsova M, Ogola G, et al. Increasing health care burden of chronic liver disease compared with other chronic diseases, 2004–2013. Gastroenterology. 2018;155(3):719–29e4. doi:10.1053/j.gastro.2018.05.032
   PubMed Web of Science ®Google Scholar
• Keenan PS, Normand SL, Lin Z, et al. An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes. 2008;1(1):29–37. doi:10.1161/CIRCOUTCOMES.108.802686
   PubMed Web of Science ®Google Scholar
• Krumholz HM, Lin Z, Drye EE, et al. An administrative claims measure suitable for profiling hospital performance based on 30-day all-cause readmission rates among patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2011;4(2):243–252. doi:10.1161/CIRCOUTCOMES.110.957498
   PubMed Web of Science ®Google Scholar
• Kanwal F, Tapper EB, Ho C, et al. Development of quality measures in cirrhosis by the practice metrics committee of the American association for the study of liver diseases. Hepatology. 2019;69(4):1787–1797. doi:10.1002/hep.30489
   PubMed Web of Science ®Google Scholar
• Kim DH, Glynn RJ, Avorn J, et al. Validation of a claims-based frailty index against physical performance and adverse health outcomes in the health and retirement study. J Gerontol a Biol Sci Med Sci. 2019;74(8):1271–1276. doi:10.1093/gerona/gly197
   PubMed Web of Science ®Google Scholar
• Kim DH, Patorno E, Pawar A, et al. Measuring frailty in administrative claims data: comparative performance of four claims-based frailty measures in the US medicare data. J Gerontol a Biol Sci Med Sci. 2020;75(6):1120–1125. doi:10.1093/gerona/glz224
   PubMed Web of Science ®Google Scholar
• Gautam N, Bessette L, Pawar A, et al. Updating international classification of diseases 9th revision to 10th revision of a claims-based frailty index. J Gerontol a Biol Sci Med Sci. 2021;76(7):1316–1317. doi:10.1093/gerona/glaa150
   PubMed Web of Science ®Google Scholar
• Gagne JJ, Glynn RJ, Avorn J, et al. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol. 2011;64(7):749–759. doi:10.1016/j.jclinepi.2010.10.004
   PubMed Web of Science ®Google Scholar
• Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263–272. doi:10.1378/chest.09-1584
   PubMed Web of Science ®Google Scholar